Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available. Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 185 Results

Clear All Filters

Title	Intervention	Indication	Therapeutic Area	Year	Actions
Tezepelumab for treating severe chronic rhinosinusitis with nasal polyps	Tezepelumab (AMG 157; MEDI9929)	Nasal polyps , Rhinosinusitis	Ear Nose and Throat (ENT)	2023	View \| Download
Tenecteplase for treating acute ischaemic stroke	Tenecteplase	Acute ischaemic stroke	Cardiovascular System	2023	View \| Download
Telisotuzumab vedotin for previously treated c-MET overexpressing EGFR wild-type non-squamous non-small cell lung cancer	Telisotuzumab vedotin (ABBV-399;ABBV 399;ABBV399;ABT-399;Teliso-V)	Non-small-cell lung cancer (NSCLC)	Lung and Respiratory Cancer	2023	View \| Download
Tazemetostat for treating relapsed or refractory follicular lymphoma after two therapies	Tazemetostat (E7438;EPZ-6438;Tazverik)	Follicular lymphoma	Haematological Cancer and Lymphomas	2023	View \| Download
TAS-102 with bevacizumab for treating refractory metastatic colorectal cancer after 2 previous therapies	Bevacizumab (Avastin; R 435; RG 405; RG 435) , Lonsurf; TAS-102 (fixed dose combination: Trifluridine; Tipiracil hydrochloride)	Colorectal cancer	Gastrointestinal Cancer , Oncology	2023	View \| Download
Tarlatamab for relapsed/refractory small-cell lung cancer	Tarlatamab	Small-cell lung cancer (SCLC)	Lung and Respiratory Cancer	2023	View \| Download
Tafasitamab with lenalidomide as add-on therapy for previously treated follicular lymphoma or marginal zone lymphoma	Lenalidomide (Revlimid) , Tafasitamab (MOR208; Monjuvi)	Follicular lymphoma , Marginal zone lymphoma (MZL)	Haematological Cancer and Lymphomas	2023	View \| Download
Subcutaneous isatuximab with pomalidomide and dexamethasone for treating relapsed and/or refractory multiple myeloma	Dexamethasone (dexamethasone sodium metasulfobenzoate) , Pomalidomide (Imnovid; CC-4047; Pomalyst) , Subcutaneous isatuximab	Multiple myeloma (MM)	Haematological Cancer and Lymphomas	2023	View \| Download
Sparsentan for treating primary IgA nephropathy	Sparsentan (RE-021; PS433540)	IgA nephropathy	Immunology , Nephrology	2023	View \| Download
Sirolimus-eluting collagen implant for preventing vascular access failure in end stage renal disease patients undergoing haemodialysis	Sirolimus-eluting collagen implant	Renal disease	Cardiovascular System , Immunology	2023	View \| Download